Abstract
Background: Endotheliopathy is a key element in COVID-19 pathophysiology, contributing to both morbidity and mortality. Biomarkers distinguishing different COVID-19 phenotypes from sepsis syndrome remain poorly understood.
Objective: To characterize circulating biomarkers of endothelial damage in different COVID-19 clinical disease stages compared with sepsis syndrome and normal volunteers.
Methods: Patients with COVID-19 pneumonia (n = 49) were classified into moderate, severe, or critical (life-threatening) disease. Plasma samples were collected within 48 to 72 h of hospitalization to analyze endothelial activation markers, including soluble Vascular Cell Adhesion Molecule-1 (sVCAM-1), von Willebrand Factor (VWF), A disintegrin-like and metalloprotease with thrombospondin type 1 motif no. 13 (ADAMTS-13) activity, thrombomodulin (TM), and soluble TNF receptor I (sTNFRI); heparan sulfate (HS) for endothelial glycocalyx degradation; C5b9 deposits on endothelial cells in culture and soluble C5b9 for complement activation; circulating dsDNA for neutrophil extracellular traps (NETs) presence, and α2-antiplasmin and PAI-1 as parameters of fibrinolysis. We compared the level of each biomarker in all three COVID-19 groups and healthy donors as controls (n = 45). Results in critically ill COVID-19 patients were compared with other intensive care unit (ICU) patients with septic shock (SS, n = 14), sepsis (S, n = 7), and noninfectious systemic inflammatory response syndrome (NI-SIRS, n = 7).
Results: All analyzed biomarkers were increased in COVID-19 patients versus controls (P < 0.001), except for ADAMTS-13 activity that was normal in both groups. The increased expression of sVCAM-1, VWF, sTNFRI, and HS was related to COVID-19 disease severity (P < 0.05). Several differences in these parameters were found between ICU groups: SS patients showed significantly higher levels of VWF, TM, sTNFRI, and NETS compared with critical COVID-19 patients and ADAMTS-13 activity was significantly lover in SS, S, and NI-SIRS versus critical COVID-19 (P < 0.001). Furthermore, α2-antiplasmin activity was higher in critical COVID-19 versus NI-SIRS (P < 0.01) and SS (P < 0.001), whereas PAI-1 levels were significantly lower in COVID-19 patients compared with NI-SIRS, S, and SS patients (P < 0.01).
Conclusions: COVID-19 patients present with increased circulating endothelial stress products, complement activation, and fibrinolytic dysregulation, associated with disease severity. COVID-19 endotheliopathy differs from SS, in which endothelial damage is also a critical feature of pathobiology. These biomarkers could help to stratify the severity of COVID-19 disease and may also provide information to guide specific therapeutic strategies to mitigate endotheliopathy progression.
【초록키워드】 COVID-19, COVID-19 pneumonia, Biomarker, Biomarkers, intensive care, Stress, endotheliopathy, thrombomodulin, Hospitalization, Pneumonia, Neutrophil extracellular traps, disease severity, neutrophil, Sepsis, complement, endothelial damage, progression, fibrinolysis, ICU, COVID-19 disease, Complement activation, heparan sulfate, Critically ill, Culture, pathophysiology, severity of COVID-19, endothelial cells, Patient, von Willebrand factor, Control, Septic shock, Neutrophil extracellular trap, morbidity and mortality, receptor, information, disease, Critical, moderate, volunteers, NETs, therapeutic strategy, COVID-19 patients, vWF, TNF, Endothelial cell, SIRS, COVID-19 patient, critically ill COVID-19 patients, except for, dysregulation, sulfate, Phenotypes, endothelial, Activation, Factor, sepsis syndrome, increased expression, both groups, healthy donors, plasma samples, fibrinolytic, syndrome, systemic inflammatory response, help, COVID-19 disease severity, Stage, life-threatening, COVID-19 group, circulating, e parameters, critical COVID-19 patients, adhesion, clinical disease, motif, significantly lower, parameter, mitigate, systemic inflammatory response syndrome, healthy donor, ADAMTS, dsDNA, COVID-19 phenotype, Result, analyzed, collected, significantly, significantly higher, contributing to, critical COVID-19 patient, in both groups, was related, with COVID-19, 【제목키워드】 COVID-19, septic,